Formulation and characterization of taste masked ondansetron–magnesium aluminum silicate adsorption systems

References

• Ogata T, Tanaka D, Ozeki T. Enhancing the solubility and masking the bitter taste of propiverine using crystalline complex formation. Drug Dev Ind Pharm 2014;40:1084–91.
   PubMed Web of Science ®Google Scholar
• Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, et al. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins. Drug Dev Ind Pharm 2015;41:1006–16.
   PubMed Web of Science ®Google Scholar
• Yehia SA, El-Ridi MS, Tadros MI, El-Sherif NG. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers. Pharm Dev Technol 2015;20:528–39.
   PubMed Web of Science ®Google Scholar
• Rao MR, Bhingole RC. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution. Drug Dev Ind Pharm 2015;27:1–8.
   Google Scholar
• Guhmann M, Preis M, Gerber F, et al. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations. Drug Dev Ind Pharm 2015;41:540–51.
   PubMed Web of Science ®Google Scholar
• Xu M, Heng PW, Liew CV. Evaluation of coat uniformity and taste-masking efficiency of irregular-shaped drug particles coated in a modified tangential spray fluidized bed processor. Expert Opin Drug Deliv 2015;11:1–10.
   Google Scholar
• Cantor SL, Khan MA, Gupta A. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride. Drug Dev Ind Pharm 2015;41:1156–64.
   PubMed Web of Science ®Google Scholar
• Ge Z, Yang M, Wang Y, et al. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin. Drug Dev Ind Pharm 2015;41:934–41.
   PubMed Web of Science ®Google Scholar
• Monteagudo E, Langenheim M, Salerno C, et al. Pharmaceutical optimization of lipid-based dosage forms for the improvement of taste-masking, chemical stability and solubilizing capacity of Phenobarbital. Drug Dev Ind Pharm 2014;40:783–92.
   PubMed Web of Science ®Google Scholar
• Kharb V, Saharan VA, Kharb V, et al. Formulation and evaluation of lipid based taste masked granules of ondansetron HCl. Eur J Pharm Sci 2014;62:180–8.
   PubMed Web of Science ®Google Scholar
• Kharb V, Saharan VA, Singh A, et al. Bitterness suppression of oral pharmaceuticals. In: Lynch EJ, Petrov AP, eds. The sense of taste. New York: Nova Science Publishers Inc., 2012:236–76.
   Google Scholar
• Idson B, Stanley M. Cold tablet. 1971; U.S. Patent 3,567,819.
   Google Scholar
• Mozda RF. Medicament adsorbates and their preparation. 1988; U.S. Patent 4,753,800.
   Google Scholar
• Caldwell HC, Desai AJ. Oral compositions of H2-antagonists. 1997; U.S. Patent 5,622,980.
   Google Scholar
• Kashid N, Chouhan P, Mukherji G. Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate. 2007; U.S. Patent Application 2010/0226979 A1.
   Google Scholar
• Zenter MR. Stable and palatable pharmaceutical composition. 1967; U.S. Patent 3,337,402.
   Google Scholar
• Sheshala R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res 2011;34:1945–56.
   PubMed Web of Science ®Google Scholar
• Bora D, Borude P, Bhise K. Taste masking by spray-drying technique. AAPS PharmSciTech 2008;9:1159–64.
   PubMed Web of Science ®Google Scholar
• Kang DS, Park YJ. A rapidly disintegrable composition for masking the bitter taste of ondansetron or a pharmaceutically acceptable salt thereof, WO2004096214; 2004.
   Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid disintegrating tablets. AAPS PharmSciTech 2007;8:E1–7.
   PubMedGoogle Scholar
• Shah S, Pandya S, Bhalekar M. Molecular properties and evaluation of indion 234-ondansetron resinates. J Young Pharm 2010;2:247–51.
   PubMedGoogle Scholar
• British Pharmacopoeia, VolumeII. London: The Stationary office; 2009:1506–8.
   Google Scholar
• Singh B, Kaur T, Singh S. Correction of raw dissolution data for loss of drug and volume during sampling. Indian J Pharm Sci 1997;59:196–9.
   Google Scholar
• Gao Y, Cui F, Guan Y, et al. Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int J Pharm 2006;318:62–9.
   PubMed Web of Science ®Google Scholar
• Anand V, Kataria M, Kukkar V, et al. The latest trends in the taste assessment of pharmaceuticals. Drug Discov Today 2007;12:257–65.
   PubMed Web of Science ®Google Scholar
• Anand V, Kharb V, Kataria M, et al. Taste assessment trials for sensory analysis of oral pharmaceutical products. Pak J Pharm Sci 2008;21:438–50.
   PubMed Web of Science ®Google Scholar
• Shirai Y, Sogo K, Yamamoto K, et al. A novel fine granule system for masking bitter taste. Biol Pharm Bull 1993;16:172–7.
   PubMed Web of Science ®Google Scholar
• Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci 1998;87:96–100.
   PubMed Web of Science ®Google Scholar
• Dev K. In vitro taste assessment method development for reduction of reliance on taste panel. M. Pharm. Thesis., Seth G. L. Bihani S. D. College of Technical Education, Sri Ganganagar, Rajasthan, India; 2012.
   Google Scholar
• Kharb V, Saharan VA, Dev K, et al. Formulation, evaluation and 3(2) full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres. Pharm Dev Technol 2014;19:839–52.
   PubMed Web of Science ®Google Scholar
• Rojtanatanya S, Pongjanyakul T. Propranolol-magnesium aluminium silicate complex dispersions and particles: characterization and factors influencing drug release. Int J Pharm 2010;383:106–15.
   PubMed Web of Science ®Google Scholar
• Aguzzi C, Cerezo P, Viseras C, Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Applied Clay Sci 2007;36:22–36.
   Web of Science ®Google Scholar
• Salem II, Lopez JMR, Galan AC. Ondansetron hydrochloride. In: Brittain HG, ed. Analytical profiles of drug substances and excipients volume 27. San Diego (CA): Academic Press. 2001:301–38.
   Google Scholar
• Joshi GV, Kevadiya BD, Patel HA, et al. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int J Pharm 2009;374:53–7.
   PubMed Web of Science ®Google Scholar
• Parolo ME, Savini MC, Valles JM, et al. Tetracycline adsorption on montmorillonite: pH and ionic strength effects. Appl Clay Sci 2008;40:179–86.
   Web of Science ®Google Scholar
• Aramă C, Varvara A, Monciu CM. Development and validation of a new capillary zone electrophoresis method for the assay of ondansetron. Farmacia 2011;59:34–43.
   Web of Science ®Google Scholar
• McGinity JW, Lach JL. In vitro adsorption of various pharmaceutical to montmorillonite. J Pharm Sci 1976;65:896–902.
   PubMed Web of Science ®Google Scholar
• Chivate A, Sargar V, Nalawade P, Tawde V. Formulation and development of oral dry suspension using taste masked Ornidazole particles prepared using Kollicoat® Smartseal 30 D. Drug Dev Ind Pharm 2013;39:1091–7.
   PubMed Web of Science ®Google Scholar
• Rahman Z, Zidan AS, Khan SR, et al. Cholorpheniramine tannate complexes: physicochemical, chemometric, and taste masking evaluation. Int J Pharm 2012;436:582–92.
   PubMed Web of Science ®Google Scholar
• Brniak W, Maślak E, Jachowicz R. Orodispersible films and tablets with prednisolone microparticles. Eur J Pharm Sci 2015;75:81–90.
   PubMed Web of Science ®Google Scholar
• Denick J. Jr, Peters D, Liao WC, Medicament adsorbates with complex magnesium aluminium silicate and their preparation. 1987; U.S. Patent 4,711,774.
   Google Scholar
• Zhang Y, Huang G, Yu Y, et al. Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2006;23:597–600.
   PubMedGoogle Scholar
• Malik RK, Malik P, Gulati N, Nagaich U. Fabrication and in vitro evaluation of mucoadhesive ondansetron hydrochloride beads for the management of emesis in chemotherapy. Int J Pharm Investig 2013;3:42–6.
   PubMedGoogle Scholar